Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Endocrine 1

Conditions

Neuroendocrine Tumors 5Neuroblastoma 2Medulloblastoma 2Carcinoma, Neuroendocrine 2von Hippel-Lindau Disease 1Tumor Positron-Emission Tomography 1Squamous Cell Carcinoma of Head and Neck 1Somatostatinoma 1Prostatic Neoplasms 1Parathyroid Neoplasms 1Multiple Endocrine Neoplasia 1Meningioma 1Hypoglycemia 1Hyperparathyroidism 1Hypercalcemia 1Carcinoid Tumor 1Cancer Diagnosis 1

Interventions

Cinacalcet 3parathyroid hormone-related peptide (1-36) 1gallium Ga 68 dotatate 1fluorodopa F 18 1etelcalcetide hydrochloride 1Saline Solution 1Calcitriol 1Bupivacaine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Hyperparathyroidism × gallium Ga 68 dotatate × Clear all
NCT00001277 2022-06-07

Studies of Elevated Parathyroid Activity

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
1,553 enrolled 8 charts
EndocrineHead & Neck

Hypercalcemia, Hyperparathyroidism, Hypoglycemia, Multiple Endocrine Neoplasia, Parathyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡